Skip to main content
Clinical Trials/NCT01611441
NCT01611441
Completed
Not Applicable

Investigation of Biomarkers in an Exploratory Study in Patients With Osteoarthritis of the Knee Undergoing Total Knee Replacement Surgery

AstraZeneca2 sites in 2 countries125 target enrollmentDecember 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis of the Knee
Sponsor
AstraZeneca
Enrollment
125
Locations
2
Primary Endpoint
Proportion of patients with upregulation of IL-6 or the IL-6 signalling pathway in the knee.
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The main purpose of the study is to better understand how specific proteins/markers in blood, urine, synovial fluid (a lubricating fluid secreted by the membrane lining the joints), and joint tissue are involved in osteoarthritis of the knee. The aim is to investigate if there is a correlation between x-ray results, specific proteins/markers and different types of pain in patients with osteoarthritis of the knee. The study consists of 3 visits over 3-20 days and the last visit will be the day of surgery.

Detailed Description

Investigation of Biomarkers in an Exploratory Study in Patients with Osteoarthritis of the Knee Undergoing Total Knee Replacement Surgery

Registry
clinicaltrials.gov
Start Date
December 2011
End Date
June 2012
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients who will undergo a total knee replacement due to osteoarthritis.
  • Symptoms of the knee for at least 6 months prior to study start.

Exclusion Criteria

  • Key-hole surgery performed on target knee within 3 months prior to study start.
  • History of disorders in which part of the immune system is missing or defective.

Outcomes

Primary Outcomes

Proportion of patients with upregulation of IL-6 or the IL-6 signalling pathway in the knee.

Time Frame: 3-20 days prior to day 1 (surgery) and day 1 (surgery) .

Secondary Outcomes

  • Biomarkers by Magnetic Resonance Imaging (MRI).(1-5 days prior to day 1 (surgery).)
  • Polymorphisms in 10 specific genes.(3-20 days prior to day 1 (surgery) or at any time in the study.)
  • Biomarkers in synovial fluid, synovial membrane, and cartilage.(Day 1 (surgery).)
  • Biomarkers in blood and urine.(3-20 days prior to day 1 (surgery) and day 1 (surgery).)
  • WOMAC (Western Ontario and McMaster Osteoarthritis Index) variables and NPQ (Neuropathic Pain Questionnaire) variables.(3-20 days prior to day 1 (surgery) and 1-5 days prior to day 1 (surgery).)

Study Sites (2)

Loading locations...

Similar Trials